Glasgow prognostic score and body mass index predict short-term discontinuation of the antifibrotic agents pirfenidone and nintedanib.
Takehara K, Koga Y, Hachisu Y, Utsugi M, Sawada Y, Saito Y, Yoshimi S, Yatomi M, Tsurumaki H, Shin Y, Wakamatsu I, Kasahara N, Yamaguchi K, Umetsu K, Kouno S, Nakagawa J, Sunaga N, Maeno T, Hisada T.
Takehara K, et al. Among authors: sunaga n.
Respir Investig. 2024 May;62(3):388-394. doi: 10.1016/j.resinv.2024.02.012. Epub 2024 Mar 8.
Respir Investig. 2024.
PMID: 38460356